Licensing as a Commercialisation Strategy for German Biotechnology Firms

Roland Helm and Michael Dowling

No 01/2007, Jena Research Papers in Business and Economics - Working and Discussion Papers (Expired!) from Friedrich Schiller University Jena, School of Economics and Business Administration

Abstract: Due to a lack of resources in new high-tech firms market access is quite diffcult. Furthermore, they do not have a reputation in the market for reliable products. Contractual arrangements with more established firms, such as licensing agreements, are one way for new firms to profit from technological innovation. The aim of this study is to investigate how country differences between German and American biotechnology firms affect the usage of licensing as a commercialisation strategy.

Keywords: High-tech firms; interfirm cooperation; licensing; innovations; reputation (search for similar items in EconPapers)
Date: 2007-01-30
References: Add references at CitEc
Citations:

Published as "Licensing as a Commercialisation Strategy for Biotechnology Firms", in: Chen, J., Xu, Q., Wu, X. (Eds.): Managing Total Innovation and Open Innovation in the 21st Century, 2007, Zhejiang University Press: Hangzhou, S.1149-1152.

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:jen:jenjbe:2007-01

Access Statistics for this paper

More papers in Jena Research Papers in Business and Economics - Working and Discussion Papers (Expired!) from Friedrich Schiller University Jena, School of Economics and Business Administration
Bibliographic data for series maintained by Markus Pasche ().